Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (32)

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

2021

  1. An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity

    Clinical Cancer Research, Vol. 27, Núm. 11, pp. 3167-3177

2020

  1. Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib

    Journal of Pathology, Vol. 252, Núm. 1, pp. 29-40

2018

  1. Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells

    Cancer Letters, Vol. 388, pp. 262-268

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

    Annals of Hematology, Vol. 94, Núm. 3, pp. 379-392

  3. Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

    Cancer Cell, Vol. 28, Núm. 2, pp. 170-182

2014

  1. Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine

    PLoS ONE, Vol. 9, Núm. 3

  2. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization

    Journal of Immunology, Vol. 193, Núm. 10, pp. 5181-5189

  3. Nickel-resistance determinants in acidiphilium sp. Pm identified by genome-wide functional screening

    PLoS ONE, Vol. 9, Núm. 4

2013

  1. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype

    Leukemia, Vol. 27, Núm. 4, pp. 925-931

2012

  1. C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, Núm. 8, pp. 1366-1377

  2. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs

    Leukemia, Vol. 26, Núm. 6, pp. 1329-1337

  3. Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562

    Experimental Biology and Medicine, Vol. 237, Núm. 8, pp. 933-942

2010

  1. Antimicrobial Peptides and Their Superior Fluorinated Analogues: Structure-Activity Relationships as Revealed by NMR Spectroscopy and MD Calculations

    Chembiochem : a European journal of chemical biology, Vol. 11, Núm. 17, pp. 2424-2432

  2. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia

    PLoS ONE, Vol. 5, Núm. 8

  3. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

    Blood, Vol. 115, Núm. 3, pp. 615-625

2003

  1. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements

    Blood, Vol. 102, Núm. 9, pp. 3252-3261

2002

  1. An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas

    Cancer Research, Vol. 62, Núm. 11, pp. 3167-3174